Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H42N |
Molecular Weight | 284.5435 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC[N+](C)(C)C
InChI
InChIKey=RLGQACBPNDBWTB-UHFFFAOYSA-N
InChI=1S/C19H42N/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(2,3)4/h5-19H2,1-4H3/q+1
DescriptionCurator's Comment: Description was created based on several sources, including http://www.americanpharmaceuticalreview.com/Featured-Articles/38886-Antimicrobial-Preservatives-Part-One-Choosing-a-Preservative-System/ | https://books.google.ru/books?id=EMrSBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.ncbi.nlm.nih.gov/pubmed/9880479 | http://www.medindia.net/doctors/drug_information/cetrimide.htm
Curator's Comment: Description was created based on several sources, including http://www.americanpharmaceuticalreview.com/Featured-Articles/38886-Antimicrobial-Preservatives-Part-One-Choosing-a-Preservative-System/ | https://books.google.ru/books?id=EMrSBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.ncbi.nlm.nih.gov/pubmed/9880479 | http://www.medindia.net/doctors/drug_information/cetrimide.htm
Cetrimide is a quaternary ammonium compound. Cetrimide was first introduced as a combined cleanser and skin antiseptic by Barnes (1942). Cetrimide combines excellent detergent properties and minimal toxicity with a useful antiseptic action. Cetrimide affects membrane permeability allowing ‘leaking’ of essential cell constituents leading to cell death. This medication is a skin antiseptic and disinfectant prescribed for seborrhoeic dermatitis and wound cleansing. The cream has a bactericidal activity against gram-positive bacteria and incompatible with soaps and other anionic surfactants.
Originator
Sources: http://savlonbangladesh.com/about-us/
Curator's Comment: Cetrimide was first introduced as a combined cleanser and skin antiseptic by Barnes (1942). http://www.sciencedirect.com/science/article/pii/S0140673600701000 reference retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18132350
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0002194 Sources: https://www.ncbi.nlm.nih.gov/pubmed/31262888 |
|||
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | CETRIMIDE Approved UseCetrimide is a skin antiseptic and disinfectant prescribed for seborrhoeic dermatitis and wound cleansing. The cream has a bactericidal activity against gram-positive bacteria and incompatible with soaps and other anionic surfactants. |
|||
Primary | CETRIMIDE Approved UseCetrimide is a skin antiseptic and disinfectant prescribed for seborrhoeic dermatitis and wound cleansing. The cream has a bactericidal activity against gram-positive bacteria and incompatible with soaps and other anionic surfactants. |
Sample Use Guides
Wound cleansing - Topical : Adult: Apply 0.1-1% aqueous solution or 0.5% cream onto affected area.
Seborrhoeic dermatitis - Topical : Adult: Apply 10% shampoo solution onto the scalp.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13990631
Cetrimide, at 30 ug/ml inhibited growth of Aspergillus niger.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
R02AA17
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
||
|
WHO-VATC |
QD08AJ02
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
||
|
WHO-VATC |
QR02AA17
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
||
|
WHO-ATC |
D08AJ02
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000084706
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
2681
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
DB01718
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
Z7FF1XKL7A
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
C79724
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
DTXSID3047978
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
39561
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
C004322
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
20614
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | RxNorm | ||
|
6899-10-1
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
3082
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
SUB01174MIG
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY | |||
|
Z7FF1XKL7A
Created by
admin on Fri Dec 15 17:40:25 GMT 2023 , Edited by admin on Fri Dec 15 17:40:25 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)